Nancy Ryan Gray - Net Worth and Insider Trading
Nancy Ryan Gray Net Worth
The estimated net worth of Nancy Ryan Gray is at least $580,143 dollars as of 2024-09-21. Nancy Ryan Gray is the Director of Ligand Pharmaceuticals Inc and owns about 5,633 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $580,143. Details can be seen in Nancy Ryan Gray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Ryan Gray has not made any transactions after 2024-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy Ryan Gray
Nancy Ryan Gray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy Ryan Gray owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Nancy Ryan Gray’s form 4 insider trades.
Insider Ownership Summary of Nancy Ryan Gray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-05-09 | director |
Nancy Ryan Gray Latest Holdings Summary
Nancy Ryan Gray currently owns a total of 1 stock. Nancy Ryan Gray owns 5,633 shares of Ligand Pharmaceuticals Inc (LGND) as of May 9, 2024, with a value of $580,143.
Latest Holdings of Nancy Ryan Gray
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-05-09 | 5,633 | 102.99 | 580,143 |
Holding Weightings of Nancy Ryan Gray
Nancy Ryan Gray Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy Ryan Gray has made a total of 1 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 934 shares on May 9, 2024, which brought Nancy Ryan Gray around $77,709.
Insider Trading History of Nancy Ryan Gray
- 1
Nancy Ryan Gray Trading Performance
Nancy Ryan Gray Ownership Network
Nancy Ryan Gray Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Nancy Ryan Gray is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Nancy Ryan Gray made 1 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 934. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 54,701 shares made by Matthew E Korenberg , a net sale of 11,800 shares made by Andrew Reardon , and a net sale of 13,433 shares made by Octavio Espinoza .
In summary, during the past 3 months, insiders sold 38,603 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 2,500 shares, with a net sale of 36,103 shares. During the past 18 months, 100,021 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 93,521 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Nancy Ryan Gray Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy Ryan Gray. You might contact Nancy Ryan Gray via mailing address: C/o Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Ste 110, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
